ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Clinical trial NCT02855944 · COMPLETED

Trial details

NCT number: NCT02855944
Sponsor: pharmaand GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Cancer Epithelial Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer

Start date: 2017-03-01
Primary completion: 2020-12-03
Enrollment: 349

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.